Cargando…

Myeloma–Bone Interaction: A Vicious Cycle via TAK1–PIM2 Signaling

SIMPLE SUMMARY: Myeloma cells interact with their ambient cells in the bone, such as bone marrow stromal cells, osteoclasts, and osteocytes, resulting in enhancement of osteoclastogenesis and inhibition of osteoblastogenesis while enhancing their growth and drug resistance. The activation of the TAK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harada, Takeshi, Hiasa, Masahiro, Teramachi, Jumpei, Abe, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431187/ https://www.ncbi.nlm.nih.gov/pubmed/34503251 http://dx.doi.org/10.3390/cancers13174441

Ejemplares similares

Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
por: Teramachi, Jumpei, et al.
Publicado: (2023)

A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration
por: Amachi, Ryota, et al.
Publicado: (2016)

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma
por: Teramachi, Jumpei, et al.
Publicado: (2020)

Sensory nerves: A driver of the vicious cycle in bone metastasis?
por: Yoneda, Toshiyuki, et al.
Publicado: (2021)

Pathogenesis and treatment of multiple myeloma bone disease
por: Hiasa, Masahiro, et al.
Publicado: (2021)

Mechanical unloading aggravates bone destruction and tumor expansion in myeloma
por: Tanimoto, Kotaro, et al.
Publicado: (2021)

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
por: Nakaue, Emiko, et al.
Publicado: (2023)

Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase
por: Harada, Takeshi, et al.
Publicado: (2022)

Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation
por: Hanson, Derek James, et al.
Publicado: (2015)

Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma
por: Watanabe, Keiichiro, et al.
Publicado: (2021)

Heart and Brain Failure: The Vicious Cycle of the Heart-Brain Interaction
por: Ishikawa, Joji, et al.
Publicado: (2023)

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors
por: Bat-Erdene, Ariunzaya, et al.
Publicado: (2016)

Effective impairment of myeloma cells and their progenitors by hyperthermia
por: Miki, Hirokazu, et al.
Publicado: (2017)

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ
por: Iwasa, Masami, et al.
Publicado: (2019)

Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis
por: Hurchla, Michelle A., et al.
Publicado: (2012)

Complaints as starting point for vicious cycles in customer–employee-interactions
por: Traut-Mattausch, Eva, et al.
Publicado: (2015)

PIM Kinases in Multiple Myeloma
por: Wu, Jian, et al.
Publicado: (2021)

Vicious Cycle between Brain and Muscle
por: Chung, Beom Sun
Publicado: (2019)

Brain-lung interaction: a vicious cycle in traumatic brain injury
por: Chacón-Aponte, Ariana Alejandra, et al.
Publicado: (2022)

TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression
por: Tenshin, Hirofumi, et al.
Publicado: (2022)

Targeting the Pim kinases in multiple myeloma
por: Keane, N A, et al.
Publicado: (2015)

Calcium Homeostasis: A Potential Vicious Cycle of Bone Metastasis in Breast Cancers
por: Yang, Zhengfeng, et al.
Publicado: (2020)

Gene Therapy Leaves a Vicious Cycle
por: Goswami, Reena, et al.
Publicado: (2019)

The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction
por: Ge, Mengyuan, et al.
Publicado: (2020)

Diabetes and climate change: breaking the vicious cycle
Publicado: (2023)

TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
por: Takeuchi, Kyoko, et al.
Publicado: (2010)

Intradialytic Hypotension and Cardiac Remodeling: A Vicious Cycle
por: Chao, Chia-Ter, et al.
Publicado: (2015)

Infectious Diseases, Livestock, and Climate: A Vicious Cycle?
por: Ezenwa, Vanessa O., et al.
Publicado: (2020)

Sepsis-associated encephalopathy: a vicious cycle of immunosuppression
por: Ren, Chao, et al.
Publicado: (2020)

A View on Pathogenesis of ≪Vicious Cancer Progression Cycle≫
por: Schwartsburd, Polina
Publicado: (2020)

The vicious cycle: a history of obesity and COVID-19
por: Bil, Jacek, et al.
Publicado: (2021)

Superior Mesenteric Artery Syndrome: A Vicious Cycle?
por: Jawed, Aleeza, et al.
Publicado: (2023)

Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration
por: Villalón-García, Irene, et al.
Publicado: (2022)

The vicious cycle of BRASH syndrome: A case report
por: Saini, Twinkle, et al.
Publicado: (2023)

Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression
por: Solimando, Antonio G., et al.
Publicado: (2020)

An overview of pim kinase as a target in multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2023)

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2
por: Higa, Yoshiki, et al.
Publicado: (2023)

A vicious partnership between AKT and PHLDA3 to facilitate neuroendocrine tumors
por: Takikawa, Masahiro, et al.
Publicado: (2017)

c-MYC and SIRT1 locked in a vicious cycle
por: Menssen, Antje, et al.
Publicado: (2012)

Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes
por: Alejandro, Emilyn U., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ts02tb7jljpuvdnh4j2t46vdm1